Retinoic acid (RA) is capable of inducing the differentiation of various myelomonocytic cell lines. During this differentiation process, the levels of c-myb expression decline, suggesting that the RA receptor (RAR) may act in part by down-regulating this proto-oncogene. We have now investigated whether the RAR can also inhibit the function of Myb proteins themselves. We have found that transcriptional activation of a Myb-responsive reporter gene can be inhibited by RA in a human monocytic cell line. This inhibition could not be overcome by the expression of exogenous Myb. The RAR did not interfere with DNA binding by Myb proteins in vitro, suggesting that the functional inhibition occurs at the level of transcriptional activation. To determine the biological relevance of the inhibition of Myb proteins by the RAR, we have used v-myb-transformed monoblasts. These cells differentiate into macrophages in the presence of phorbol ester (tetradecanoyl phorbol acetate [TPA]) but are normally unresponsive to RA treatment. The introduction of an inducible, exogenous RAR alpha into v-myb-transformed monoblasts permitted an RA-dependent differentiation into macrophage-like cells similar to those induced by TPA. These results demonstrate that transformation by v-myb is recessive to RAR alpha and imply that many types of non-RA-responsive leukemia cells may become responsive following the introduction of the RAR.

Department of Genetics and Molecular Biology Faculty of Science Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Curr Top Microbiol Immunol. 1975;71:79-101 PubMed

Semin Cancer Biol. 1993 Dec;4(6):359-67 PubMed

Proc Natl Acad Sci U S A. 1980 May;77(5):2936-40 PubMed

Proc Natl Acad Sci U S A. 1982 Apr;79(7):2194-8 PubMed

J Mol Appl Genet. 1982;1(4):327-41 PubMed

Proc Natl Acad Sci U S A. 1983 Mar;80(5):1421-5 PubMed

Cell. 1983 Aug;34(1):7-9 PubMed

Mol Cell Biol. 1984 Dec;4(12):2587-93 PubMed

J Virol. 1987 Oct;61(10):3004-12 PubMed

Mol Cell Biol. 1987 Aug;7(8):2745-52 PubMed

Cell. 1988 Jul 29;54(3):313-23 PubMed

Science. 1988 Dec 2;242(4883):1303-6 PubMed

J Virol. 1989 Apr;63(4):1651-60 PubMed

Nature. 1989 Jun 22;339(6226):593-7 PubMed

Blood. 1989 Jul;74(1):99-102 PubMed

Nature. 1989 Jul 20;340(6230):242-4 PubMed

Cell. 1989 Dec 22;59(6):1115-25 PubMed

Mol Cell Biol. 1990 May;10(5):2285-93 PubMed

Biochim Biophys Acta. 1990 Jun 1;1032(1):39-52 PubMed

Cell. 1990 Dec 21;63(6):1289-97 PubMed

Cell. 1991 May 17;65(4):677-89 PubMed

Mol Cell Biol. 1991 Aug;11(8):3987-96 PubMed

Oncogene. 1991 Jul;6(7):1285-92 PubMed

Cell. 1991 Aug 23;66(4):663-74 PubMed

Cell. 1991 Aug 23;66(4):675-84 PubMed

Cell. 1991 Sep 6;66(5):885-93 PubMed

Science. 1991 Nov 29;254(5036):1371-4 PubMed

Oncogene. 1992 Feb;7(2):203-16 PubMed

Curr Opin Cell Biol. 1991 Dec;3(6):928-34 PubMed

Biochim Biophys Acta. 1992 Sep 14;1114(1):51-62 PubMed

Blood. 1992 Oct 15;80(8):1885-9 PubMed

Trends Biochem Sci. 1992 Oct;17(10):427-33 PubMed

Genes Dev. 1992 Dec;6(12A):2258-69 PubMed

Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1590-4 PubMed

Recent Prog Horm Res. 1993;48:99-121 PubMed

Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7225-9 PubMed

Gene. 1993 Dec 27;137(1):145-9 PubMed

Cell. 1994 Jan 28;76(2):333-43 PubMed

Cell. 1994 Jan 28;76(2):345-56 PubMed

Oncogene. 1994 Jan;9(1):237-45 PubMed

Mol Cell Biol. 1994 Mar;14(3):2129-39 PubMed

Proc Natl Acad Sci U S A. 1978 May;75(5):2458-62 PubMed

c-Myb interferes with inflammatory IL1α-NF-κB pathway in breast cancer cells

c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis